Angiotensin Converting Enzyme Inhibitors Market, Global Outlook and Forecast 2022-2028

February 2022 | 67 pages | ID: A39EA2FBB0A8EN
Market Monitor Global

Abstracts

Angiotensin converting enzyme inhibitors (ACE inhibitors) are medications that slow (inhibit) the activity of the enzyme ACE, which decreases the production of angiotensin II.

This report contains market size and forecasts of Angiotensin Converting Enzyme Inhibitors in Global, including the following market information:

Global Angiotensin Converting Enzyme Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Angiotensin Converting Enzyme Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Benazepril (Lotensin) Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Angiotensin Converting Enzyme Inhibitors include Pfizer, AstraZeneca, Novartis AG, Daiichi Sankyo, Inc, Sanofi, Merck and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Angiotensin Converting Enzyme Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Angiotensin Converting Enzyme Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Angiotensin Converting Enzyme Inhibitors Market Segment Percentages, by Type, 2021 (%)

• Benazepril (Lotensin)
• Captopril
• Enalapril (Vasotec)
• Fosinopril
• Lisinopril (Prinivil, Zestril)
• Moexipril
• Perindopril
• Quinapril (Accupril)
• Ramipril (Altace)
• Trandolapril

Global Angiotensin Converting Enzyme Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Angiotensin Converting Enzyme Inhibitors Market Segment Percentages, by Application, 2021 (%)

• Coronary Artery Disease
• Heart Failure
• Diabetes
• Chronic Kidney Diseases
• Heart Attacks
• Scleroderma
• Migraines
• Others

Global Angiotensin Converting Enzyme Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Angiotensin Converting Enzyme Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Angiotensin Converting Enzyme Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Angiotensin Converting Enzyme Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• AstraZeneca
• Novartis AG
• Daiichi Sankyo, Inc
• Sanofi
• Merck
• Abbott

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Angiotensin Converting Enzyme Inhibitors Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Angiotensin Converting Enzyme Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANGIOTENSIN CONVERTING ENZYME INHIBITORS OVERALL MARKET SIZE

2.1 Global Angiotensin Converting Enzyme Inhibitors Market Size: 2021 VS 2028
2.2 Global Angiotensin Converting Enzyme Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Angiotensin Converting Enzyme Inhibitors Players in Global Market
3.2 Top Global Angiotensin Converting Enzyme Inhibitors Companies Ranked by Revenue
3.3 Global Angiotensin Converting Enzyme Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Angiotensin Converting Enzyme Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies Angiotensin Converting Enzyme Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Angiotensin Converting Enzyme Inhibitors Players in Global Market
  3.6.1 List of Global Tier 1 Angiotensin Converting Enzyme Inhibitors Companies
  3.6.2 List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme Inhibitors Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Angiotensin Converting Enzyme Inhibitors Market Size Markets, 2021 & 2028
  4.1.2 Benazepril (Lotensin)
  4.1.3 Captopril
  4.1.4 Enalapril (Vasotec)
  4.1.5 Fosinopril
  4.1.6 Lisinopril (Prinivil, Zestril)
  4.1.7 Moexipril
  4.1.8 Perindopril
  4.1.9 Quinapril (Accupril)
  4.1.10 Ramipril (Altace)
  4.1.11 Trandolapril
4.2 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue & Forecasts
  4.2.1 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2022
  4.2.2 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2023-2028
  4.2.3 By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Angiotensin Converting Enzyme Inhibitors Market Size, 2021 & 2028
  5.1.2 Coronary Artery Disease
  5.1.3 Heart Failure
  5.1.4 Diabetes
  5.1.5 Chronic Kidney Diseases
  5.1.6 Heart Attacks
  5.1.7 Scleroderma
  5.1.8 Migraines
  5.1.9 Others
5.2 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue & Forecasts
  5.2.1 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2022
  5.2.2 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2023-2028
  5.2.3 By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Angiotensin Converting Enzyme Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue & Forecasts
  6.2.1 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2022
  6.2.2 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue, 2023-2028
  6.2.3 By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2028
  6.3.2 US Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.3.3 Canada Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.3.4 Mexico Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2028
  6.4.2 Germany Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.4.3 France Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.4.4 U.K. Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.4.5 Italy Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.4.6 Russia Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.4.7 Nordic Countries Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.4.8 Benelux Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2028
  6.5.2 China Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.5.3 Japan Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.5.4 South Korea Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.5.5 Southeast Asia Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.5.6 India Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2028
  6.6.2 Brazil Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.6.3 Argentina Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2028
  6.7.2 Turkey Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.7.3 Israel Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.7.4 Saudi Arabia Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028
  6.7.5 UAE Angiotensin Converting Enzyme Inhibitors Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.1.4 Pfizer Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 AstraZeneca
  7.2.1 AstraZeneca Corporate Summary
  7.2.2 AstraZeneca Business Overview
  7.2.3 AstraZeneca Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.2.4 AstraZeneca Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.2.5 AstraZeneca Key News
7.3 Novartis AG
  7.3.1 Novartis AG Corporate Summary
  7.3.2 Novartis AG Business Overview
  7.3.3 Novartis AG Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.3.4 Novartis AG Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.3.5 Novartis AG Key News
7.4 Daiichi Sankyo, Inc
  7.4.1 Daiichi Sankyo, Inc Corporate Summary
  7.4.2 Daiichi Sankyo, Inc Business Overview
  7.4.3 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.4.4 Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.4.5 Daiichi Sankyo, Inc Key News
7.5 Sanofi
  7.5.1 Sanofi Corporate Summary
  7.5.2 Sanofi Business Overview
  7.5.3 Sanofi Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.5.4 Sanofi Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.5.5 Sanofi Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.6.4 Merck Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Abbott
  7.7.1 Abbott Corporate Summary
  7.7.2 Abbott Business Overview
  7.7.3 Abbott Angiotensin Converting Enzyme Inhibitors Major Product Offerings
  7.7.4 Abbott Angiotensin Converting Enzyme Inhibitors Revenue in Global Market (2017-2022)
  7.7.5 Abbott Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Angiotensin Converting Enzyme Inhibitors Market Opportunities & Trends in Global Market
Table 2. Angiotensin Converting Enzyme Inhibitors Market Drivers in Global Market
Table 3. Angiotensin Converting Enzyme Inhibitors Market Restraints in Global Market
Table 4. Key Players of Angiotensin Converting Enzyme Inhibitors in Global Market
Table 5. Top Angiotensin Converting Enzyme Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Angiotensin Converting Enzyme Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Angiotensin Converting Enzyme Inhibitors Revenue Share by Companies, 2017-2022
Table 8. Global Companies Angiotensin Converting Enzyme Inhibitors Product Type
Table 9. List of Global Tier 1 Angiotensin Converting Enzyme Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Angiotensin Converting Enzyme Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Angiotensin Converting Enzyme Inhibitors Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 32. Pfizer Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 35. AstraZeneca Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)
Table 36. Novartis AG Corporate Summary
Table 37. Novartis AG Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 38. Novartis AG Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)
Table 39. Daiichi Sankyo, Inc Corporate Summary
Table 40. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 41. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)
Table 42. Sanofi Corporate Summary
Table 43. Sanofi Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 44. Sanofi Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 47. Merck Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)
Table 48. Abbott Corporate Summary
Table 49. Abbott Angiotensin Converting Enzyme Inhibitors Product Offerings
Table 50. Abbott Angiotensin Converting Enzyme Inhibitors Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Angiotensin Converting Enzyme Inhibitors Segment by Type in 2021
Figure 2. Angiotensin Converting Enzyme Inhibitors Segment by Application in 2021
Figure 3. Global Angiotensin Converting Enzyme Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Angiotensin Converting Enzyme Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Angiotensin Converting Enzyme Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Angiotensin Converting Enzyme Inhibitors Revenue in 2021
Figure 8. By Type - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 9. By Application - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 10. By Region - Global Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Country - North America Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 12. US Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 16. Germany Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 17. France Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 24. China Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. India Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 30. Brazil Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Angiotensin Converting Enzyme Inhibitors Revenue Market Share, 2017-2028
Figure 33. Turkey Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Angiotensin Converting Enzyme Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. AstraZeneca Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Novartis AG Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Daiichi Sankyo, Inc Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sanofi Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Abbott Angiotensin Converting Enzyme Inhibitors Revenue Year Over Year Growth (US$, Mn) & (2017-2022)